X4 Pharmaceuticals, Inc. (XFOR)

X4 Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	97.41	99.22	121.72	81.79	78.71	126.18
Short-Term Investments	37.57	15	-	-	-	-
Cash & Short-Term Investments	134.98	114.22	121.72	81.79	78.71	126.18
Cash Growth	-4.73%	-6.16%	48.82%	3.91%	-37.62%	1451.32%
Other Receivables	1.07	0.56	1.15	0.75	0.92	2
Receivables	1.07	0.56	1.15	0.75	0.92	2
Prepaid Expenses	4.48	7.05	5.52	5.34	3.42	1.1
Restricted Cash	-	0.25	0.29	-	0.26	-
Total Current Assets	142.97	122.08	128.68	87.88	83.31	129.28
Property, Plant & Equipment	5.29	6.4	8.33	10.22	9.2	2.36
Goodwill	17.35	17.35	17.35	17.35	27.11	27.11
Other Long-Term Assets	2.36	1.44	1.23	1.72	3.26	1.95
Total Assets	178.17	147.26	155.59	117.18	122.87	160.7
Accounts Payable	8.58	8.95	7.78	4.28	3.14	2.09
Accrued Expenses	19.46	12.82	11.44	7.85	8.02	6.46
Current Portion of Long-Term Debt	-	-	1.32	0.8	-	-
Current Portion of Leases	1.22	1.1	1.2	1.08	0.79	0.9
Other Current Liabilities	-	-	0.59	0.03	-	-
Total Current Liabilities	29.26	22.86	22.32	14.02	11.95	9.45
Long-Term Debt	75.22	54.57	32.3	33.14	33.18	20.1
Long-Term Leases	1.76	2.61	3.6	4.78	4.48	1.92
Other Long-Term Liabilities	12.31	16.12	23.3	0.83	0.46	0.02
Total Liabilities	118.54	96.16	81.54	52.76	50.07	31.48
Common Stock	0.17	0.17	0.12	0.03	0.02	0.02
Additional Paid-In Capital	535.1	528.96	450.79	347.37	267.08	261.37
Retained Earnings	-475.53	-477.91	-376.74	-282.87	-194.18	-132.04
Comprehensive Income & Other	-0.11	-0.12	-0.12	-0.12	-0.12	-0.12
Total Common Equity	59.62	51.1	74.05	64.41	72.8	129.22
Shareholders' Equity	59.62	51.1	74.05	64.41	72.8	129.22
Total Liabilities & Equity	178.17	147.26	155.59	117.18	122.87	160.7
Total Debt	78.2	58.28	38.42	39.79	38.45	22.91
Net Cash (Debt)	56.77	55.94	83.3	42	40.26	103.27
Net Cash Growth	-31.92%	-32.85%	98.32%	4.33%	-61.02%	-
Net Cash Per Share	0.28	0.31	1.31	1.63	2.01	8.96
Filing Date Shares Outstanding	170.55	167.94	122.21	30.81	17.38	16.13
Total Common Shares Outstanding	168.51	167.43	121.67	28.13	16.31	16.13
Working Capital	113.71	99.21	106.35	73.86	71.36	119.83
Book Value Per Share	0.35	0.31	0.61	2.29	4.46	8.01
Tangible Book Value	32.08	33.75	56.7	47.06	45.69	102.11
Tangible Book Value Per Share	0.19	0.20	0.47	1.67	2.80	6.33
Machinery	2.39	2.11	2.08	1.98	1.25	0.34
Leasehold Improvements	0.23	0.23	0.23	0.23	0.23	0.3

Source: S&P Capital IQ. Standard template. Financial Sources.